Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com

Posted by ABMN Staff on Apr 30th, 2025

StockNews.com initiated coverage on shares of Aethlon Medical (NASDAQ:AEMD – Free Report) in a report released on Tuesday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $7.00 price target on shares of Aethlon Medical in a report on Monday, March 10th.

View Our Latest Report on AEMD

Aethlon Medical Stock Up 4.8 %

NASDAQ AEMD opened at $0.42 on Tuesday. The company has a market cap of $6.68 million, a PE ratio of -0.26 and a beta of 1.71. Aethlon Medical has a 52 week low of $0.24 and a 52 week high of $1.79. The firm’s 50-day simple moving average is $0.41 and its two-hundred day simple moving average is $0.49.

Aethlon Medical (NASDAQ:AEMD – Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The medical equipment provider reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.09. As a group, equities research analysts anticipate that Aethlon Medical will post -0.73 EPS for the current year.

Institutional Investors Weigh In On Aethlon Medical

Institutional investors and hedge funds have recently modified their holdings of the company. Renaissance Technologies LLC purchased a new stake in shares of Aethlon Medical in the fourth quarter worth about $25,000. Allegiance Financial Group Advisory Services LLC purchased a new stake in shares of Aethlon Medical in the fourth quarter worth about $26,000. Sassicaia Capital Advisers LLC bought a new position in shares of Aethlon Medical in the fourth quarter worth approximately $31,000. Virtu Financial LLC purchased a new stake in Aethlon Medical in the fourth quarter valued at approximately $81,000. Finally, Boothbay Fund Management LLC bought a new stake in Aethlon Medical during the fourth quarter valued at approximately $186,000. 1.99% of the stock is owned by hedge funds and other institutional investors.

About Aethlon Medical

(Get Free Report)

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.